Zusammenfassung
Therapie der Wahl maligner Lidtumoren ist die chirurgische Exzision. Falls dies nicht möglich oder gewünscht ist, steht eine Reihe alternativer Therapien zur Verfügung. Als systemische Präparate kommen für Basalzellkarzinome Vismodegib und Sonidegib, für Plattenepithelkarzinome Cetuximab und Cemiplimab infrage. Bei oberflächlichen Tumoren ist eine Kryodestruktion möglich. In-situ-Befunde können mit den lokalen Präparaten Imiquimod oder 5‑Fluoruracil sowie mit der photodynamischen Therapie behandelt werden. Die interdisziplinäre Zusammenarbeit mit Kollegen der Dermatologie ist empfehlenswert.
Abstract
The treatment of choice for malignant eyelid tumors is surgical excision. If this is not feasible or undesirable, a number of alternative treatments are available. Possible systemic preparations are vismodegib and sonidegib for basal cell carcinoma as well as cetuximab and cemiplimab for squamous cell carcinoma. Cryodestruction is possible for superficial tumors. In situ findings can be treated with the local preparations imiquimod or 5‑fluorouracil and with photodynamic therapy. An interdisciplinary cooperation with dermatologists is advisable.
Literatur
Anders M, Sporl E, Krantz H, Matthaus W, Seiler T (1995) Cryotherapy of malignant eyelid tumors. Ophthalmologe 92(6):787–792
Avril M, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, Guillaume J, Chalon R, Petit J, Sancho-Garnier H, Prade M, Bouzy J, Chassagne D (1997) Basal cell carcinoma of the face: surgery or radiotherapy? results of a randomized study. Br J Cancer 76(1):100–106. https://doi.org/10.1038/bjc.1997.343
Buschmann W (2002) A reappraisal of cryosurgery for eyelid basal cell carcinomas. Br J Ophthalmol 86(4):453–457
Cannon PS, O’Donnell B, Huilgol SC, Selva D (2011) The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions. Br J Ophthalmol 95(12):1682–1685. https://doi.org/10.1136/bjo.2009.178202
Cox KF, Margo CE (2016) Role of vismodegib in the management of advanced periocular basal cell carcinoma. Cancer Control 23(2):133–139. https://doi.org/10.1177/107327481602300207
Crowe DL, Hacia JG, Hsieh CL, Sinha UK, Rice H (2002) Molecular pathology of head and neck cancer. Histol Histopathol 17(3):909–914. https://doi.org/10.14670/HH-17.909
Daicker B, Buchner S, Kraus M (1994) Conjunctivalization of Meibomian glands following cryosurgery for basal cell carcinoma of the eyelid. Eur J Ophthalmol 4(1):59–61
Durkin SR, Roos D, Higgs B, Casson RJ, Selva D (2007) Ophthalmic and adnexal complications of radiotherapy. Acta Ophthalmol Scand 85(3):240–250. https://doi.org/10.1111/j.1600-0420.2006.00822.x
Fitzpatrick PJ, Thompson GA, Easterbrook WM, Gallie BL, Payne DG (1984) Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radiat Oncol Biol Phys 10(4):449–454. https://doi.org/10.1016/0360-3016(84)90023-3
Gastaud L, Rossignol B, Peyrade F, Re D, Thariat J, Thyss A, Doyen J (2016) Role of radiotherapy in the management of non-Hodgkin lymphomas. Cancer Radiother 20(3):236–247. https://doi.org/10.1016/j.canrad.2016.01.011
Kaufmann R (1997) Chemotherapie des Basalioms. In: Garbe C, Dummer R, Kaufmann R, Tilgen W (Hrsg) Dermatologische Onkologie. Springer, Berlin Heidelberg, S 166–172
Ko D‑Y, Jeon S‑Y, Kim K‑H, Song K‑H (2014) Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study. J Eur Acad Dermatol Venereol 28(11):1529–1539. https://doi.org/10.1111/jdv.12334
Kwa RE, Campana K, Moy RL (1992) Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26(1):1–26. https://doi.org/10.1016/0190-9622(92)70001-v
Limawararut V, Leibovitch I, Sullivan T, Selva D (2007) Periocular squamous cell carcinoma. Clin Experiment Ophthalmol 35(2):174–185. https://doi.org/10.1111/j.1442-9071.2006.01411.x
Luxenberg MN, Guthrie TH (1986) Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues. Ophthalmology 93(4):33708–33704. https://doi.org/10.1016/s0161-6420
Mandel VD, Ferrari F, Ciardo S, Giusti F, Pellacani G (2017) Bowen’s disease of the upper eyelid successfully treated with photodynamic therapy. J Eur Acad Dermatol Venereol 31(2):e127–e129. https://doi.org/10.1111/jdv.13875
Migden MR, Rischin D, Schmults CD, Guminski A, Hauschild A, Lewis KD et al (2018) PD‑1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med 379(4):341–351. https://doi.org/10.1056/NEJMoa1805131
Ogata D, Tsuchida T (2019) Systemic immunotherapy for advanced cutaneous squamous cell carcinoma. Curr Treat Options in Oncol 20(4):30. https://doi.org/10.1007/s11864-019-0629-2
Paoli J, Gyllencreutz JD, Fougelberg J, Backman EJ, Modin M, Polesie S, Zaar O (2019) Nonsurgical options for the treatment of basal cell carcinoma. Dermatol Pract Concept 9(2):75–81. https://doi.org/10.5826/dpc.0902a01
Preneau S, Rio E, Brocard A, Peuvrel L, Nguyen J‑M, Quéreux G, Dreno B (2014) Efficacy of cetuximab in the treatment of squamous cell carcinoma. J Dermatolog Treat 25(5):424–427. https://doi.org/10.3109/09546634.2012.751481
Stoscheck CM, King LE (1986) Role of epidermal growth factor in carcinogenesis. Cancer Res 46(3):1030–1037
Svendsen FH, Heegaard S (2017) Lymphoma of the eyelid. Surv Ophthalmol 62(3):312–331. https://doi.org/10.1016/j.survophthal.2016.11.009
Tchanque-Fossuo CN, Eisen DB (2018) A systematic review on the use of cryotherapy versus other treatments for basal cell carcinoma. Dermatol Online J 24(11):3
Weiling M, Bergua A, Kruse FE, Holbach L (2016) Therapie bei malignen Lidtumoren. Ophthalmologe 113(12):1095–1108. https://doi.org/10.1007/s00347-016-0387-5
Wittels W (1964) Experiences and indications for therapy with liquid nitrogen. Arch Klin Exp Dermatol 219:693–696
Wong S‑F (2005) Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer. Clin Ther 27(6):684–694. https://doi.org/10.1016/j.clinthera.2005.06.003
Wong KY, Fife K, Lear JT, Price RD, Durrani AJ (2017) Vismodegib for locally advanced periocular and orbital basal cell carcinoma: a review of 15 consecutive cases. Plast Reconstr Surg Glob Open 5(7):e1424. https://doi.org/10.1097/GOX.0000000000001424
Yin VT, Pfeiffer ML, Esmaeli B (2013) Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg 29(2):87–92. https://doi.org/10.1097/IOP.0b013e3182831bf3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Girbardt, A. Mößner, P. Wiedemann und S. Grunewald geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.
Rights and permissions
About this article
Cite this article
Girbardt, C., Mößner, A., Wiedemann, P. et al. Therapiealternativen zur chirurgischen Versorgung maligner Lidtumoren und deren Vorläuferstufen. Ophthalmologe 117, 478–483 (2020). https://doi.org/10.1007/s00347-020-01072-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-020-01072-y